Current Issue : July-September Volume : 2019 Issue Number : 3 Articles : 3 Articles
The vaccine-approval process in the United States is regulated by the Center for Biologics Evaluation and research of the US Food and Drug Administration. Throughout the life cycle of development, from preclinical studies to after licensure, vaccines are subjected to rigorous testing and oversight. Manufacturers must adhere to good manufacturing practice (GMP) and control procedures to ensure the quality of vaccines. As mandated by title 21 of the code of regulations, licensed vaccines must meet stringent criteria for safety, efficacy and potency. In section 351(a) of the public health service act (PHS), the current authorities for the regulation of vaccines are given. The present review forces on regulatory issues of vaccines....
Medicines are the tools via which we happen to raise the potential of the body to fight with wide variety of diseases. There are two categories of drugs from Market point of view across the world. These are Prescription medicines and OTC Medicines. OTC means over the counter and it means the drugs which can be taken from medical store without the help of registered medical practitioners or doctors. The present manuscript has been written in order to put across a new perspective to the world of science regarding the OTC category of Medicines....
Medicines or Drugs are made to have effective effects on the body of the patient. However this depends upon lot of factors, like composition of drug and the percentage of different ingredients in the medicine. Apart from this, it also depends upon the genetic make-up of the person’s body. Here the role of Pharmacogenetics comes into play. This short communication is put across constructive picture of Pharmacogenetics. Future Medicines would be the more so of preventive medicines which would change the complete business model of drug therapy and pharmaceutical and healthcare industry. It would help in transition from cure to prevention. Thus, it would help in making a win-win-win business model of drug discoveries, as it would benefit the manufacturer, customer and consumer in all together. Hence, the present communication would attract industry leaders and manufacturers to work on new perspective of business and drug discovery development, which would help in bringing out the industry from present crisis state of affairs. Drug discovery in the form of preventive medicines would help in developing the body for future attacks and make it ready to deal with any untoward outcomes or happenings....
Loading....